S. Nakashima

402 total citations
49 papers, 256 citations indexed

About

S. Nakashima is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, S. Nakashima has authored 49 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 14 papers in Immunology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in S. Nakashima's work include Systemic Lupus Erythematosus Research (15 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Pregnancy and Medication Impact (6 papers). S. Nakashima is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Pregnancy and Medication Impact (6 papers). S. Nakashima collaborates with scholars based in Japan, United States and Belarus. S. Nakashima's co-authors include Hiroaki Dobashi, Hiromi Shimada, Tomohiro Kameda, Norimitsu Kadowaki, Nobuyuki Miyatake, Osamu Imataki, Noriyuki Kurata, Masayuki Inoo, Yusuke Ushio and Hiroaki Onishi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

S. Nakashima

40 papers receiving 249 citations

Peers

Countries citing papers authored by S. Nakashima

Since Specialization

Citations

This map shows the geographic impact of S. Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Nakashima more than expected).

Fields of papers citing papers by S. Nakashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Nakashima. The network helps show where S. Nakashima may publish in the future.

Co-authorship network of co-authors of S. Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of S. Nakashima. A scholar is included among the top collaborators of S. Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Nakashima. S. Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Avacopan is effective in inducing remission for MPA/GPA, regardless of changes in serum C5a levels: a single-center study in Japan 2025 ·BMC Rheumatology ·Yusuke Ushio, Hiromi Shimada, (unknown), S. Nakashima, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	0
2	Clinical characteristics and quality of life of patients with Behcet’s disease with arthritis in Japan 2024 ·Scientific Reports ·(unknown), (unknown), Tomohiro Kameda, Hiromi Shimada, S. Nakashima, (unknown), Yusuke Ushio, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	1
3	Immunological disease activity parameters at conception are risk factors for preterm birth and low birth weight in patients with systemic lupus erythematosus 2023 ·Lupus ·Hiromi Shimada, (unknown), Tomohiro Kameda, S. Nakashima, (unknown), (unknown), Yusuke Ushio, (unknown), (unknown), (unknown), Kenji Kanenishi, Norimitsu Kadowaki, Hiroaki Dobashi	1
4	[18F] FDG uptake in patients with spondyloarthritis: correlation with serum inflammatory biomarker levels 2023 ·EJNMMI Research ·(unknown), Takashi Norikane, Yuka Yamamoto, (unknown), Hiromi Shimada, (unknown), S. Nakashima, Hiroaki Dobashi, Yoshihiro Nishiyama	4
5	AB1489 CLINICAL COURSES AND PREGNANCY OUTCOMES OF TWELVE CASES COMPLICATED WITH BEHCET'S DISEASE IN OUR INSTITUTION 2023 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), S. Nakashima, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
6	Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric study 2022 ·Medicine ·(unknown), (unknown), Tomohiro Kameda, Hiromi Shimada, S. Nakashima, (unknown), (unknown), Yusuke Ushio, (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	3
7	Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease 2022 ·Clinical Rheumatology ·(unknown), (unknown), Hiromi Shimada, S. Nakashima, Tomohiro Kameda, Nobuyuki Miyatake, (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	3
8	Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behçet's disease 2022 ·Dermatologic Therapy ·(unknown), Yusuke Ushio, (unknown), Tomohiro Kameda, Hiromi Shimada, S. Nakashima, (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	4
9	Effect of add-on hydroxychloroquine therapy on serum proinflammatory cytokine levels in patients with systemic lupus erythematosus 2022 ·Scientific Reports ·(unknown), (unknown), S. Nakashima, Hiromi Shimada, Tomohiro Kameda, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	6
10	Systemic lupus erythematosus with various clinical manifestations in a patient with hereditary angioedema: a case report 2022 ·Allergy Asthma and Clinical Immunology ·Yusuke Ushio, (unknown), Tomohiro Kameda, S. Nakashima, Hiromi Shimada, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Emi Ibuki, Norimitsu Kadowaki, Hiroaki Dobashi	0
11	Preterm birth is strongly affected by the glucocorticoid dose during pregnancy in women complicated by systemic lupus erythematosus 2022 ·Arthritis Research & Therapy ·Hiromi Shimada, (unknown), Kenji Kanenishi, Nobuyuki Miyatake, S. Nakashima, (unknown), (unknown), (unknown), (unknown), Yusuke Ushio, (unknown), (unknown), Tomohiro Kameda, Norimitsu Kadowaki, Hiroaki Dobashi	16
12	FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis 2022 ·Scientific Reports ·Tomohiro Kameda, S. Nakashima, (unknown), Yuka Yamamoto, Takashi Norikane, Hiromi Shimada, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	3
13	Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report 2021 ·Allergy Asthma and Clinical Immunology ·(unknown), (unknown), Hiromi Shimada, (unknown), Tomohiro Kameda, S. Nakashima, (unknown), Yusuke Ushio, Norimitsu Kadowaki, Hiroaki Dobashi	4
14	Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study 2021 ·Rheumatology and Therapy ·Sei Muraoka, (unknown), (unknown), Wataru Hirose, Hajime Kono, Shinsuke Yasuda, Yukiko Komano, Hiroshi Kawano, Toshihiko Hidaka, S. Nakashima, Tsuyoshi Kasama, Tamio Teramoto, Toshihiro Nanki, (unknown)	10
15	Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab 2020 ·Modern Rheumatology Case Reports ·(unknown), Tomohiro Kameda, (unknown), Hiroki Ozaki, S. Nakashima, Hiromi Shimada, Norimitsu Kadowaki, Hiroaki Dobashi	8
16	The development of rapidly progressive glomerulonephritis associated with both antineutrophil cytoplasmic antibody-associated vasculitis and anti-glomerular basement membrane nephritis in the course of nontuberculous mycobacterium infection: a case report 2020 ·BMC Rheumatology ·(unknown), (unknown), Tomohiro Kameda, (unknown), Tadashi Sofue, Yusuke Ushio, (unknown), S. Nakashima, Hiromi Shimada, (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	3
17	Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus 2019 ·Lupus ·(unknown), Tomohiro Kameda, (unknown), S. Nakashima, Hiromi Shimada, (unknown), (unknown), (unknown), Nobuyuki Miyatake, Norimitsu Kadowaki, Hiroaki Dobashi	13
18	Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers 2019 ·Clinical Rheumatology ·Hiromi Shimada, Tomohiro Kameda, Kenji Kanenishi, Nobuyuki Miyatake, S. Nakashima, (unknown), (unknown), (unknown), (unknown), Toshiyuki Hata, Norimitsu Kadowaki, Hiroaki Dobashi	16
19	PRACTICAL USE OF THE WAVE PREDICTION SYSTEM AND ACTUAL CONDITION OF ACCESS FOR MAINTENANCE OF OFFSHORE WIND POWER 2015 ·Journal of Japan Society of Civil Engineers Ser B3 (Ocean Engineering) ·S. Nakashima, Shin‐ichi Inaba, (unknown), (unknown), (unknown)	1
20	Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report 2015 ·BMC Research Notes ·Hiromi Shimada, Hiroaki Dobashi, Hisanori Morimoto, Tomohiro Kameda, (unknown), (unknown), (unknown), S. Nakashima, Osamu Imataki, Shuji Bandoh	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact